Advertisement

Comparison of intensity-modulated radiation therapy (IMRT), 3D conformal proton therapy and intensity-modulated proton therapy (IMPT) for the treatment of metastatic brain cancer

Published:January 22, 2023DOI:https://doi.org/10.1016/j.meddos.2023.01.001

      Abstract

      The purpose of this study has been to compare photon intensity modulated radiation therapy (IMRT) against both conformal and intensity modulated proton therapy (IMPT) plans for metastatic brain cancer. Ten IMRT patients with brain cancer were chosen retrospectively, with prescription doses in the range of 20 to 40 Gy, delivered in 3 to 5 fractions using Varian TrueBeam STx machine. Three proton plans with proton double scattering, single collimation static-IMPT, and energy layer by layer collimation dynamic-IMPT were then generated for the same patients using the Mevion S250 system for conformal plans and the S250i system for IMPT plans. Each plan had respective treatment planning systems that include Brainlab iPlan for IMRT, Varian Eclipse for proton double scattering, and RaySearch Raystation for IMPT. Dosimetric and radiobiologic comparisons were made through dose-volume histogram (DVH) analysis of the target and the organs at risk (OAR); and with parameters of equivalent uniform dose (EUD), tumor control probability (TCP), and normal tissue complication probability (NTCP), respectively. A set of variables α/β ratio, survival fraction, and clonogenic cell density were selected and varied to observe their effect on the abovementioned parameters. Doses were observed to be more homogeneous for patients with brain malignancies with photon IMRT treatments, while dose conformity is improved with proton PBS treatments. Normal tissue is, on average, spared more through both proton treatment options. The minimum doses, closely approximated by dose to 98% of the target volume, are similar across treatment modalities with slight variations.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Medical Dosimetry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mishra K
        • Daftari IK.
        Proton therapy for the management of uveal melanoma and other ocular tumors.
        Chi Clin Oncol. 2016; 5: 50
        • Slater JD
        • Yonemoto LT
        • Ross Jr, CJ
        • et al.
        Conformal proton therapy for prostate carcinoma.
        Int J Radiat Oncol Biol Phys. 1998; 42: 299-304
        • Noel G
        • Habrand JL
        • Jauffret E
        • et al.
        Radiation therapy for chorfoma and chondrosarcoma of the skull base and the cervical spine: Prognostic factors and pattern of failure.
        Strahlenther Onkol. 2003; 179: 241-248
        • Cozzi L
        • Fogiliata A
        • Lomax A
        • Bolsi A.
        A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumors.
        Radiother Oncol. 2001; 61: 287-297
        • Paganetti H
        Proton Therapy Physics.
        CRC Press, Boca Raton, Florida2019
        • Grewal HS
        • Ahmad S
        • Jin H.
        Performance evaluation of adaptive aperture's static and dynamic collimation in a compact pencil beam scanning proton therapy system: A dosimetric comparison study for multiple disease sites.
        Med Dosimetry. 2021; 46: 179-187
        • Tommasino Fr
        • Nahum A
        • Cella L.
        Increasing the power of tumour control and normal tissue complication probability modelling in radiotherapy: Recent trends and current issues.
        Transl Cancer Res. 2017; 6
        • Allen LX
        • Alber M
        • Deasy JO
        • et al.
        The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the Therapy Physics Committee of the AAPM.
        Med Physics. 2012; 39: 1386-1409
        • Kataria T
        • Sharma K
        • Subramani V
        • et al.
        Homogeneity index: An objective tool for assessment of conformal radiation treatments.
        J Med Phys. 2012; 37: 207-213
        • Stanley J
        • Brietman K
        • Dunscombe P
        • et al.
        Evaluation of Stereotactic Radio-surgery Conformity Indices for 170 Target Volumes in Patients with Brain Metas-tases.
        JACMP. 2011; 12: 245-253
        • Niemierko A.
        Reporting and analyzing dose distributions: A concept of equivalent uniform dose.
        Medical Physics. 1997; 24: 103-110
      1. Kendall, E. Gamma Knife and LINAC based stereotactic treatments of intracranial targets: Dosimetric and radiobiological considerations. A Thesis submitted for the degree of Master of Science, University of Oklahoma HSC, Oklahoma City; 2017

        • Kendall E
        • Algan O
        • Ahmad S.
        Comparison of volumetric modulated arc therapy and intensity modulated radiation therapy for whole brain hippocampal sparing treatment plans based on radiobiological modeling.
        JMed Phys. 2018; 43: 16-22
        • Ahmad S
        • Vogds B
        • McKenna F
        • Vlachaki MT.
        Tumor control probability (TCP) in prostate cancer: Role of radiobiological parameters and radiation dose escalation.
        J X-Ray Sci Technol. 2009; 17: 347-354
        • Lyman JT.
        Complication probability as assessed from dose-volume histograms.
        Radiat Res Suppl. 1985; 8: S13-S19
        • Matthiesen C
        • Herman TDLF
        • Singh H
        • et al.
        Dosimetric and radiobiologic comparison of 3D Conformal, IMRT, VMAT and proton therapy for the treatment of early stage glottic cancer.
        J Med Imaging Radiat Oncol. 2015; 59: 221-228
        • De La Fuente Herman T
        • Ahmad S
        • Vlachaki MT.
        Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for treatment of high-grade glioma: A radiobiological modeling study.
        J X-Ray Sci Technol. 2010; 18: 393-402
        • Kutcher GJ
        • Burman C
        • Brewster L
        • et al.
        Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.
        IJROBP. 1991; 21: 137-146
        • Burman C
        • Kutcher GJ
        • Emami B
        • Goiten M.
        Fitting of normal tissue tolerance data to an analytic function.
        IJROBP. 1991; 21: 123-135
        • Emami B
        • Lyman J
        • Brown A
        • et al.
        Tolerance of normal tissue to therapeutic irradiation.
        IJROBP. 1991; 21: 109-122
        • Dale R
        • Jones B
        Radiobiological Modelling in Radiation Oncology.
        British Institute of Radiology, 2007
        • Wigg D.
        Applied Radiobiology and Bioeffect Planning.
        Medical Physics Publishing, Madison, WN2001
        • Metcalfe P
        • Kron T
        • Hoban P
        The Physics of Radiotherapy X-Rays and Electrons.
        Medical Physics Publishing Corporation, Madison, Wisconsin2004: 450